Journal of the Pakistan Medical Association
Role of Brentuximab vedotin along With Chemotherapy in Patients with CD30 Antigen Positive Aggressive Lymphomas: Single Centre Experience from a Developing Country
By Danish Shakeel, Farrukh Ali Khan, Sana Khurram Khurram and 3 others.
Abstract
Objective
To evaluate the effectiveness and safety of brentuximab vedotin in managing Hodgkin’s lymphoma and anaplastic large cell lymphoma in patients with histologically proven aggressive cluster of differentiation-30 antigen lymphoma on biopsy.
